The broader context of implementation science

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 1, 2011, Pages

  Thomas, James C ^a,b   Curtis, Sian ^a   Smith, Jason B ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE SURVEILLANCE; ETHICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERVENTION STUDY; LETTER; MEDICAL EDUCATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCIENCE; STUDY DESIGN; ECONOMICS; FINANCIAL MANAGEMENT; GOVERNMENT; NOTE; ORGANIZATION AND MANAGEMENT; RELIEF WORK;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CAPITAL FINANCING; FEDERAL GOVERNMENT; HUMANS; RELIEF WORK;

EID: 80155174907     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822103e4     Document Type: Letter

References (9)

1. Padian NS, Holmes CB, McCoy SI, et al. Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr. 2011;56:199-203.
2. Padian NS, McCoy SI, Balkus JE, et al. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24:621-635.
3. National Bioethics Advisory Council (NBAC). Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries. Vol I. Bethesda, MD: National Bioethics Advisory Council; 2001:28.
4. Joint United Nations Programme on HIV AIDS (UNAIDS). Victora CG, Black R, Boerma JT, et al. Measuring impact in the millenium development goal era and beyond: a new approach to large-scale effectiveness evaluations. Lancet. 2011;377:85-95.
5. US Agency for International Development, the US Centers for Disease Control and Prevention, and the US Office of the Global AIDS Coordinator. Technical Consultation on Innovative Approaches to Evaluation within the Global Health Initiative. Washington, DC; US Agency for International Development, the US Centers for Disease Control and Prevention, and the US Office of the Global AIDS Coordinator. Available at: http://www.google.com/search?q=%22 technical+consultation+on+innovative+Evaluation %22&ie=utf-8&oe=utf- 8&aq=t&rls=org. mozilla:en-US:official&client=firefox-a. Accessed October 4-5, 2010.
6. Rowe AK, Steketee RW, Arnold F, et al. Evaluating the impact of malaria control efforts on mortality in sub-Saharan Africa. Trop Med Int Health. 2007;12:1524-1539. (Pubitemid 350212720)
7. Strategic Guidance for Evaluating HIV Prevention Programmes. Geneva, Switzerland: UNAIDS, 2010. Available at: http://www.unaids.org/en/media/unaids/ contentassets/documents/document/2010/12-7-MERG-Guidance-Evaluating%20HIV- PreventionProgrammes.pdf. Accessed March 23, 2011.
8. Boerma JT and Stansfield SK. Health statistics now: are we making the right investments? Lancet. 2007;369:779-786. (Pubitemid 46335825)
9. USAID, Bureau for Policy, Planning, and Learning. Evaluation policy. January 19, 2011. Available at: www.usaid.gov/evvaluation/usaid-evaluation- policy.pdf. Accessed March 22, 2011.